129 related articles for article (PubMed ID: 9428350)
1. The role of growth factors in the malignant and invasive progression of intrinsic brain tumours.
Finn PE; Bjerkvig R; Pilkington GJ
Anticancer Res; 1997; 17(6B):4163-72. PubMed ID: 9428350
[TBL] [Abstract][Full Text] [Related]
2. Expression of growth factors, growth-inhibiting factors, and their receptors in invasive breast cancer. II: Correlations with proliferation and angiogenesis.
de Jong JS; van Diest PJ; van der Valk P; Baak JP
J Pathol; 1998 Jan; 184(1):53-7. PubMed ID: 9582527
[TBL] [Abstract][Full Text] [Related]
3. Growth hormone in vascular pathology: neovascularization and expression of receptors is associated with cellular proliferation.
Lincoln DT; Singal PK; Al-Banaw A
Anticancer Res; 2007; 27(6B):4201-18. PubMed ID: 18225592
[TBL] [Abstract][Full Text] [Related]
4. Brain tumor cell invasion, anatomical and biological considerations.
Thorsen F; Tysnes BB
Anticancer Res; 1997; 17(6B):4121-6. PubMed ID: 9428345
[TBL] [Abstract][Full Text] [Related]
5. Autocrine factors that sustain glioma invasion and paracrine biology in the brain microenvironment.
Hoelzinger DB; Demuth T; Berens ME
J Natl Cancer Inst; 2007 Nov; 99(21):1583-93. PubMed ID: 17971532
[TBL] [Abstract][Full Text] [Related]
6. Expression of growth factors, growth inhibiting factors, and their receptors in invasive breast cancer. I: An inventory in search of autocrine and paracrine loops.
de Jong JS; van Diest PJ; van der Valk P; Baak JP
J Pathol; 1998 Jan; 184(1):44-52. PubMed ID: 9582526
[TBL] [Abstract][Full Text] [Related]
7. Growth factors as novel therapeutic targets in neoplastic disease.
Greig R; Dunnington D; Murthy U; Anzano M
Cancer Surv; 1988; 7(4):653-74. PubMed ID: 3072070
[TBL] [Abstract][Full Text] [Related]
8. The role of polypeptide growth factors in human carcinomas: new targets for a novel pharmacological approach.
Favoni RE; de Cupis A
Pharmacol Rev; 2000 Jun; 52(2):179-206. PubMed ID: 10835099
[TBL] [Abstract][Full Text] [Related]
9. The contribution of proangiogenic factors to the progression of malignant disease: role of vascular endothelial growth factor and its receptors.
Neufeld G; Kessler O; Vadasz Z; Gluzman-Poltorak Z
Surg Oncol Clin N Am; 2001 Apr; 10(2):339-56, ix. PubMed ID: 11382591
[TBL] [Abstract][Full Text] [Related]
10. Soluble factors involved in glioma invasion.
Mueller MM; Werbowetski T; Del Maestro RF
Acta Neurochir (Wien); 2003 Nov; 145(11):999-1008. PubMed ID: 14628206
[TBL] [Abstract][Full Text] [Related]
11. Domain swapping in a COOH-terminal fragment of platelet factor 4 generates potent angiogenesis inhibitors.
Hagedorn M; Zilberberg L; Wilting J; Canron X; Carrabba G; Giussani C; Pluderi M; Bello L; Bikfalvi A
Cancer Res; 2002 Dec; 62(23):6884-90. PubMed ID: 12460903
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of intracerebral glioblastoma growth by local treatment with the scatter factor/hepatocyte growth factor-antagonist NK4.
Brockmann MA; Papadimitriou A; Brandt M; Fillbrandt R; Westphal M; Lamszus K
Clin Cancer Res; 2003 Oct; 9(12):4578-85. PubMed ID: 14555533
[TBL] [Abstract][Full Text] [Related]
13. Vascular endothelial growth factor-A(165) induces progression of melanoma brain metastases without induction of sprouting angiogenesis.
Küsters B; Leenders WP; Wesseling P; Smits D; Verrijp K; Ruiter DJ; Peters JP; van Der Kogel AJ; de Waal RM
Cancer Res; 2002 Jan; 62(2):341-5. PubMed ID: 11809675
[TBL] [Abstract][Full Text] [Related]
14. The control of angiogenesis and tumor invasion by platelet factor-4 and platelet factor-4-derived molecules.
Bikfalvi A; Gimenez-Gallego G
Semin Thromb Hemost; 2004 Feb; 30(1):137-44. PubMed ID: 15034805
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo models for the study of brain tumour invasion.
Pilkington GJ; Bjerkvig R; De Ridder L; Kaaijk P
Anticancer Res; 1997; 17(6B):4107-9. PubMed ID: 9428342
[TBL] [Abstract][Full Text] [Related]
16. Recent advances in research on multistage tumorigenesis.
Compagni A; Christofori G
Br J Cancer; 2000 Jul; 83(1):1-5. PubMed ID: 10883659
[TBL] [Abstract][Full Text] [Related]
17. Cooperative autocrine and paracrine functions of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor in the progression of skin carcinoma cells.
Obermueller E; Vosseler S; Fusenig NE; Mueller MM
Cancer Res; 2004 Nov; 64(21):7801-12. PubMed ID: 15520186
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of vascular endothelial growth factor isoforms drives oxygenation and growth but not progression to glioblastoma multiforme in a human model of gliomagenesis.
Sonoda Y; Kanamori M; Deen DF; Cheng SY; Berger MS; Pieper RO
Cancer Res; 2003 Apr; 63(8):1962-8. PubMed ID: 12702589
[TBL] [Abstract][Full Text] [Related]
19. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
Hanrahan V; Currie MJ; Gunningham SP; Morrin HR; Scott PA; Robinson BA; Fox SB
J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739
[TBL] [Abstract][Full Text] [Related]
20. HuR, a RNA stability factor, is expressed in malignant brain tumors and binds to adenine- and uridine-rich elements within the 3' untranslated regions of cytokine and angiogenic factor mRNAs.
Nabors LB; Gillespie GY; Harkins L; King PH
Cancer Res; 2001 Mar; 61(5):2154-61. PubMed ID: 11280780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
